Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Yog Guru Swami Ramdev with Union Minister of Road Transport and Highways Nitin Gadkar and Union Minister for Health and Family Welfare Dr. Harshvardhan and Achariya Balakrishna at the launch of the first evidence-based medicine for Covid-19
The World Health Organization (WHO) clarified in a tweet that it has not reviewed or certified the efficacy of Patanjali’s Covid-19 vaccine.
This comes as Patanjali Ayurved claimed that its Coronil medicine, which was earlier vouched as an immunity booster, received certification from Ayush Ministry as per WHO’s certification scheme.
WHO’s regional office for South-East Asia posted on its official Twitter handle, “@WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19.”
Patanjali Ayurveda managing director Acharya Balkrishna also took to Twitter and revealed that the Goods Manufacturing Practice (GMP) compliant Certificate of Pharmaceutical Product (CPP) to Coronil has been given by the Drugs Controller General of India (DCGI), as per previous reports.
“It is clear that WHO does not approve or disapprove any drugs,” Balkrishna’s tweet added. He further stated that Patanjali was "clarifying to avoid confusion."
On Friday, Patanjali had claimed that its Coronil is the first of its kind 'evidence-based' medicine that can protect people from coronavirus.
The launch of Coronil was attended by union health minister Harsh Vardhan and transport minister Nitin Gadkari in the presence of Patanjali Ayurved promoter Baba Ramdev.
"Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organization as per the WHO certification scheme," Patanjali had announced in a statement.
The company had further claimed that under the Certificate of Pharmaceutical Product (CoPP), Coronil can be exported to 158 countries.
It had also stated that the Ministry of Ayush has recognized Coronil as a “supporting measure in Covid-19.”
Earlier in July 2020, the company had made claims that its vaccine could provide strong protection against the coronavirus. Later, the Ayush Ministry released a statement stating that Coronil can be sold only as an immunity booster and not as a cure.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
With initial public offerings galore, we give you a cheat sheet to score some good grades
Biggest risk in selling funds in a rising scenario is exiting early and missing out on further gains
Go for a standard vector-borne diseases policy if you don’t have a regular health plan
No credit risk is an attraction, but note the nuances
After facing severe droughts for several years, farmers in western Maharashtra have turned the corner through ...
A toast to a traditional drip irrigation system still going strong in the Northeast
Raza Mir’s ‘Murder at the Mushaira’ works well as a historical novel that captures the sunset years of the ...
If you see garbage lying on the streets, remove it, says a dedicated plogger on a clean-up drive
Its name is the starting point of a brand’s journey and can make a big difference in the success sweepstakes
Sober spirits are the in thing
A peek into where ad spends went last year and where they are headed tomorrow
Can Swiggy Instamart disrupt the ecommerce groceries space, currently ruled by the Amazons and Big Baskets? ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...